Login
← Go Back
Granules India
GRANULES · Pharma > Pharmaceuticals & Drugs · Chairman: Krishna Prasad Chigurupati · MD: Krishna Prasad Chigurupati · Listing date: June 21, 2005 · Employees: 3369 · Hyderabad · http://www.granulesindia.com
Stock Price vs Company Growth
1d
0.4%
1w
3.4%
1m
10.8%
3m
19.9%
6m
46.1%
1y
83.2%
5y
18.2%
10y
20.2%
all
27.4%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 846 0.4%
691
910
Company Overview
Sales
5,632 Cr
Growth: 16.2%
Profit after Tax
646 Cr
Growth: 11.6%
Mid Cap
20,957 Cr
P/E: 31.4x
Industry P/E: 32.3x
Fundamentals
Sales (Cr) ₹ 5,632
Growth 16.2%
EBITDA 22.7%
P/S 3.7x
Dividend 0.3%
P/E 31.4x
Book Value ₹ 212
PEG Ratio 1.9x
ROE 14.0%
P/B 4.0x
Shareholding Pattern
Institutions
Government Pension Fund Global
3.01 %
Fidelity Funds - Asian Smaller Companies Pool
1.55 %
Mahima Stocks Private Limited
1.49 %
Basava Sankara Rao Kolli
1.21 %
Iepf
0.1 %
Promoters
Krishna Prasad Chigurupati
34.84 %
Chigurupati Uma Devi
3.82 %
Tyche Investments Private Limited
1.47 %
Chigurupati Pragnya
0.76 %
Chigurupati Priyanka
0.75 %
Others
Qualified Instituional Buyer
0.15 %
Increase    Decrease    No change
Company Profile Detailed
Granules India is a vertically integrated pharmaceutical company with a presence across the entire value chain - from Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Formulation Intermediates (PFIs) to Finished Dosages (FDs). The company’s differentiated business model, combining scale, cost leadership, and regulatory compliance, allows it to serve customers across several countries.
Belongs to (32 Indices) view more
Investors (124)
mondrian...
fidelity...
share.in...
Followers (25)
nitin2
keerthi
deepak